Advertisement
Screener

Imunon, Inc. (IMNN) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

Imunon, Inc. Increase (Decrease) in Prepaid Expense and Other Assets

Imunon, Inc. (IMNN) reported Increase (Decrease) in Prepaid Expense and Other Assets of $141.62 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2024-03-28

  • Imunon, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-12-31 was $234.15K, a 1013.20% increase year-over-year.
  • Imunon, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-09-30 was $368.81K, a 62.55% increase year-over-year.
  • Imunon, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-06-30 was $201.26K.
  • Imunon, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-03-31 was -$17.50K, a 127.12% decline year-over-year.
  • Imunon, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $141.62K.
  • Imunon, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$43.98K, a 105.59% decline from fiscal 2021.
  • Imunon, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2021 was $786.72K, a 155.41% increase from fiscal 2020.
  • Imunon, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2020 was $308.02K, a 65.83% decline from fiscal 2019.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2023-12-31$141.62K
10-K · filed 2024-03-28
2022-12-31-$43.98K
10-K · filed 2024-03-28
$514.60K
10-K · filed 2023-03-30
2021-12-31$234.15K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$602.96K
derived: sum of 2 quarters · filed 2023-03-30
$804.22K
derived: sum of 3 quarters · filed 2023-03-30
$786.72K
10-K · filed 2023-03-30
2021-09-30$368.81K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$570.07K
derived: sum of 2 quarters · filed 2021-11-15
$552.57K
10-Q · filed 2021-11-15
$573.60K
derived: sum of 4 quarters · filed 2022-03-31
2021-06-30$201.26K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$183.76K
10-Q · filed 2021-08-12
$204.79K
derived: sum of 3 quarters · filed 2022-03-31
$431.68K
derived: sum of 4 quarters · filed 2022-03-31
2021-03-31-$17.50K
10-Q · filed 2021-05-14
$3.53K
derived: sum of 2 quarters · filed 2022-03-31
$230.42K
derived: sum of 3 quarters · filed 2022-03-31
$226.00K
derived: sum of 4 quarters · filed 2022-03-31
2020-12-31$21.03K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$247.92K
derived: sum of 2 quarters · filed 2022-03-31
$243.50K
derived: sum of 3 quarters · filed 2022-03-31
$308.02K
10-K · filed 2022-03-31
2020-09-30$226.89K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$222.46K
derived: sum of 2 quarters · filed 2021-11-15
$286.99K
10-Q · filed 2021-11-15
$236.49K
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$4.42K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$60.10K
10-Q · filed 2021-08-12
$9.60K
derived: sum of 3 quarters · filed 2021-08-12
$29.83K
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$64.53K
10-Q · filed 2021-05-14
$14.03K
derived: sum of 2 quarters · filed 2021-05-14
$34.25K
derived: sum of 3 quarters · filed 2021-05-14
$320.04K
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31-$50.50K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19
-$30.28K
derived: sum of 2 quarters · filed 2021-03-19
$255.51K
derived: sum of 3 quarters · filed 2021-03-19
$901.38K
10-K · filed 2021-03-19
2019-09-30$20.22K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16
$306.01K
derived: sum of 2 quarters · filed 2020-11-16
$951.88K
10-Q · filed 2020-11-16
$1.08M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$285.79K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
$931.65K
10-Q · filed 2020-08-14
$1.06M
derived: sum of 3 quarters · filed 2020-08-14
$1.28M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$645.86K
10-Q · filed 2020-05-15
$775.98K
derived: sum of 2 quarters · filed 2020-05-15
$995.97K
derived: sum of 3 quarters · filed 2020-05-15
2018-12-31$130.12K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25
$350.11K
derived: sum of 2 quarters · filed 2020-03-25
$362.11K
10-K · filed 2020-03-25
2018-09-30$219.99K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$231.99K
10-Q · filed 2018-11-14
2018-06-30$12.00K
10-Q · filed 2018-08-14
2017-12-31-$116.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
-$20.76K
derived: sum of 2 quarters · filed 2019-03-29
-$52.44K
derived: sum of 3 quarters · filed 2019-03-29
-$115.22K
10-K · filed 2019-03-29
2017-09-30-$20.64K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
-$52.32K
derived: sum of 2 quarters · filed 2018-11-14
-$115.11K
10-Q · filed 2018-11-14
2017-06-30-$31.68K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
-$94.46K
10-Q · filed 2018-08-14
2017-03-31-$62.79K
10-Q · filed 2018-05-11
2016-09-30-$174.35K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
-$45.23K
derived: sum of 2 quarters · filed 2017-11-14
$136.87K
10-Q · filed 2017-11-14
-$77.93K
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$129.12K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$311.22K
10-Q · filed 2017-08-14
$96.42K
derived: sum of 3 quarters · filed 2017-08-14
-$183.54K
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$182.10K
10-Q · filed 2017-05-12
-$32.70K
derived: sum of 2 quarters · filed 2017-05-12
-$312.66K
derived: sum of 3 quarters · filed 2017-05-12
-$464.07K
derived: sum of 4 quarters · filed 2017-05-12
2015-12-31-$214.80K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
-$494.76K
derived: sum of 2 quarters · filed 2016-11-10
-$646.17K
derived: sum of 3 quarters · filed 2016-11-10
-$246.40K
10-K · filed 2016-03-30
2015-09-30-$279.97K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
-$431.38K
derived: sum of 2 quarters · filed 2016-11-10
-$31.60K
10-Q · filed 2016-11-10
-$120.40K
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30-$151.41K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
$248.36K
10-Q · filed 2016-08-15
$159.56K
derived: sum of 3 quarters · filed 2016-08-15
$359.94K
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31$399.77K
10-Q · filed 2016-05-16
$310.97K
derived: sum of 2 quarters · filed 2016-05-16
$511.35K
derived: sum of 3 quarters · filed 2016-05-16
$220.85K
derived: sum of 4 quarters · filed 2016-05-16
2014-12-31-$88.80K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$111.57K
derived: sum of 2 quarters · filed 2016-03-30
-$178.93K
derived: sum of 3 quarters · filed 2016-03-30
-$77.47K
10-K · filed 2016-03-30
2014-09-30$200.37K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$90.13K
derived: sum of 2 quarters · filed 2015-11-05
$11.33K
10-Q · filed 2015-11-05
$103.10K
derived: sum of 4 quarters · filed 2016-03-30
2014-06-30-$290.50K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
-$189.04K
10-Q · filed 2015-08-10
-$97.28K
derived: sum of 3 quarters · filed 2016-03-30
2014-03-31$101.46K
10-Q · filed 2015-05-11
$193.22K
derived: sum of 2 quarters · filed 2016-03-30
2013-12-31$91.77K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$121.23K
10-K · filed 2016-03-30
2013-09-30$29.47K
10-Q · filed 2013-11-12
2012-12-31-$597.30K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
-$631.26K
derived: sum of 2 quarters · filed 2015-03-12
-$802.53K
derived: sum of 3 quarters · filed 2015-03-12
-$585.60K
10-K · filed 2015-03-12
2012-09-30-$33.95K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$205.22K
derived: sum of 2 quarters · filed 2013-11-12
$11.71K
10-Q · filed 2013-11-12
$641.95K
derived: sum of 4 quarters · filed 2014-03-13
2012-06-30-$171.27K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
$45.66K
10-Q · filed 2012-08-14
$675.90K
derived: sum of 3 quarters · filed 2014-03-13
$646.68K
derived: sum of 4 quarters · filed 2014-03-13
2012-03-31$216.93K
10-Q · filed 2012-05-15
$847.18K
derived: sum of 2 quarters · filed 2014-03-13
$817.95K
derived: sum of 3 quarters · filed 2014-03-13
-$562.17K
derived: sum of 4 quarters · filed 2014-03-13
2011-12-31$630.24K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
$601.01K
derived: sum of 2 quarters · filed 2014-03-13
-$779.10K
derived: sum of 3 quarters · filed 2014-03-13
$393.68K
10-K · filed 2014-03-13
2011-09-30-$29.23K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10
-$1.41M
derived: sum of 2 quarters · filed 2012-08-14
-$236.57K
10-Q · filed 2011-11-10
-$950.34K
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30-$1.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
-$207.34K
10-Q · filed 2012-08-14
-$921.11K
derived: sum of 3 quarters · filed 2013-03-18
-$967.32K
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$1.17M
10-Q · filed 2012-05-15
$459.01K
derived: sum of 2 quarters · filed 2013-03-18
$412.80K
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31-$713.77K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$759.98K
derived: sum of 2 quarters · filed 2013-03-18
-$340.84K
10-K · filed 2013-03-18
2010-09-30-$46.21K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10
$372.93K
10-Q · filed 2011-11-10
2010-06-30$419.14K
10-Q · filed 2011-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
SOLIGENIX, INC. (SNGX)United States$0.008B
EXICURE, INC. (XCUR)United States$0.008B-1.54
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97